Answer
No. It treats symptoms after a migraine attack has begun and is not licensed as preventive treatment.
Sources for this answer
- Zolmitriptan 2.5 mg Orodispersible Tablets — Current selected SmPCemc · Summary of Product Characteristics
- Zolmitriptan Grunenthal 5 mg Nasal Spray — Current selected SmPCemc · Summary of Product Characteristics
- Zolmitriptan 5 mg Film-coated Tablets — Current selected SmPCemc · Summary of Product Characteristics
- Zomig Rapimelt 2.5mg — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.